You are here:

2013

71. Aure MR, Leivonen SK, Fleischer T, Zhu Q, Overgaard J, Alsner J, Tramm T, Louhimo R, Alnæs GI, Perälä M, Busato F, Touleimat N, Tost J, Børresen-Dale AL, Hautaniemi S, Troyanskaya OG, Lingjærde OC, Sahlberg KK, Kristensen VN. Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors. Genome Biol. 2013 Nov 20;14(11):R126

70. Busk M, Horsman MR. Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment. Q J Nucl Med Mol Imaging. 2013 Sep;57(3):219-34.

69. Dieperink KB, Johansen C, Hansen S, Wagner L, Andersen KK, Minet LR, Hansen O. The effects of multidisciplinary rehabilitation: RePCa-a randomised study among primary prostate cancer patients. Br J Cancer. 2013 Oct 29.

68. Christoffersen CP, Hansen D, Poulsen P, Sorensen TS. Registration-based reconstruction of four-dimensional cone beam computed tomography. IEEE Trans Med Imaging. 2013 Nov;32(11):2064-77.

67. Bjerre T, Crijns S, af Rosenschöld PM, Aznar M, Specht L, Larsen R, Keall P. Three-dimensional MRI-linac intra-fraction guidance using multiple orthogonal cine-MRI planes. Phys Med Biol. 2013 Jul 21;58(14):4943-50.

66. Bernchou U, Schytte T, Bertelsen A, Bentzen SM, Hansen O, Brink C. Time evolution of regional CT density changes in normal lung after IMRT for NSCLC. Radiother Oncol. 2013 Sep 20.

65. Vestergaard A, Muren LP, Søndergaard J, Elstrøm UV, Høyer M, Petersen JB. Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: A dose accumulation comparison Radiother Oncol. 2013 Dec;109(3):457-62.

64. Baumann M, Bodis S, Dikomey E, van der Kogel A, Overgaard J, Rodemann HP, Wouters B. Molecular radiation biology/oncology at its best: Cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology. Radiother Oncol. 2013 Sep;108(3):357-61

63. Mortensen HR, Overgaard J, Jensen K, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen E, Andersen LJ, Hansen HS, Grau C; DAHANCA Group. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer. Acta Oncol. 2013 Oct;52(7):1535-42.

61. Offersen BV, Nielsen HM, Overgaard M, Overgaard J. Is regional nodes radiotherapy an alternative to surgery? Breast. 2013 Aug;22 Suppl 2:S118-28.

59. Nielsen T, Nielsen NC, Holm TH, Ostergaard L, Horsman MR, Busk M. Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia. Acta Oncol. 2013 Oct;52(7):1287-92.

57. Winther M, Alsner J, Tramm T, Nordsmark M. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer. Acta Oncol. 2013 Oct;52(7):1327-35.

56. Behrens CF, Andreasen TB, Lindberg H, Buhl SK, Vestergaard A, Elstrøm UV, Sjöström D. Quantitative image quality evaluation of pelvic computed tomography-based imaging systems: A novel concept in radiotherapy. Acta Oncol. 2013 Oct;52(7):1579-82.

55. Korsager AS, Stephansen UL, Carl J, Ostergaard LR. The use of an active appearance model for automated prostate segmentation in magnetic resonance. Acta Oncol. 2013 Oct;52(7):1374-7.

54. Nielsen MS, Nyström MW, Carl J. Potential position errors using fiducial markers for gated image guided radiotherapy. Acta Oncol. 2013 Oct;52(7):1472-6.

53. Ravn S, Holmberg M, Sørensen P, Frøkjær JB, Carl J. Differences in supratentorial white matter diffusion after radiotherapy - new biomarker of normal brain tissue damage? Acta Oncol. 2013 Oct;52(7):1314-9.

52. Kallehauge J, Nielsen T, Haack S, Peters DA, Mohamed S, Fokdal L, Lindegaard JC, Hansen DC, Rasmussen F, Tanderup K, Pedersen EM. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer. Acta Oncol. 2013 Oct;52(7):1360-8.

51. Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol. 2013 Oct;52(7):1510-9.

49. Skyt PS, Petersen JB, Yates ES, Poulsen PR, Ravkilde TL, Balling P, Muren LP. Dosimetric verification of complex radiotherapy with a 3D optically based dosimetry system: Dose painting and target tracking. Acta Oncol. 2013 Oct;52(7):1445-50.

48. Thörnqvist S, Hysing LB, Zolnay AG, Söhn M, Hoogeman MS, Muren LP, Heijmen BJ. Adaptive radiotherapy in locally advanced prostate cancer using a statistical deformable motion model. Acta Oncol. 2013 Oct;52(7):1423-9.

46. Sørensen BS, Busk M, Olthof N, Speel EJ, Horsman MR, Alsner J, Overgaard J. Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells. Radiother Oncol. 2013 Sep;108(3):500-5.

45. Thorsen LB, Thomsen MS, Overgaard M, Overgaard J, Offersen BV; on behalf of the Danish Breast Cancer Cooperative Group Radiotherapy Committee. Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study. Acta Oncol. 2013 Oct;52(7):1526-34.

44. Busk M, Jakobsen S, Horsman MR, Mortensen LS, Iversen AB, Overgaard J, Nordsmark M, Ji X, Lee DY, Raleigh JR. PET imaging of tumor hypoxia using 18F-labeled pimonidazole. Acta Oncol. 2013 Oct;52(7):1300-7.

43. Lønbro S, Dalgas U, Primdahl H, Johansen J, Nielsen JL, Overgaard J, Overgaard K. Lean body mass and muscle function in head and neck cancer patients and healthy individuals - results from the DAHANCA 25 study. Acta Oncol. 2013 Oct;52(7):1543-51.

42. Grau C, Høyer M, Alber M, Overgaard J, Lindegaard JC, Muren LP. Biology-guided adaptive radiotherapy (BiGART) - more than a vision? Acta Oncol. 2013 Oct;52(7):1243-7.

41. Tanderup K, Beddar S, Andersen CE, Kertzscher G, Cygler JE. In vivo dosimetry in brachytherapy. Med Phys. 2013 Jul;40(7):070902.

40. Lønbro S, Dalgas U, Primdahl H, Johansen J, Nielsen JL, Aagaard P, Hermann AP, Overgaard J, Overgaard K. Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy - Results from the randomized DAHANCA 25B trial. Radiother Oncol. 2013 Aug;108(2):314-9.

38. Schmidt ML, Hoffmann L, Kandi M, Møller DS, Poulsen PR. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer. Acta Oncol. 2013 Oct;52(7):1490-6.

36. Havelund BM, Olsen DA, Andersen RF, Spindler KL, Brandslund I, Jakobsen A, Soerensen FB. The Influence of Tissue Ischemia on Biomarker Expression in Colorectal Cancer. Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):298-307.

35. Havelund BM, Holdgaard PC, Rafaelsen SR, Mortensen LS, Theil J, Bender D, Pløen J, Spindler KL, Jakobsen A. Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancer. Nucl Med Commun. 2013 Feb;34(2):155-61.

34. Korsager AS, Carl J, Ostergaard LR. MR-CT registration using a Ni-Ti prostate stent in image-guided radiotherapy of prostate cancer. Med Phys. 2013 Jun;40(6):061907.

33. Christensen BO, Overgaard J, Kettner LO, Damsgaard TE. Long-term evaluation of postmastectomy breast reconstruction with the pedicled transverse rectus abdominis musculocutaneous flap. J Plast Surg Hand Surg. 2013 Oct;47(5):374-8.

32. Thor M, Bentzen L, Hysing LB, Ekanger C, Helle SI, Karlsdóttir A, Muren LP. Prediction of rectum and bladder morbidity following radiotherapy of prostate cancer based on motion-inclusive dose distributions. Radiother Oncol. 2013 May;107(2):147-52.

31. Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck Af Rosenschöld P, Petersen PM, Specht L. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol. 2013 Aug;24(8):2113-8.

30. Nesvacil N, Tanderup K, Hellebust TP, De Leeuw A, Lang S, Mohamed S, Jamema SV, Anderson C, Pötter R, Kirisits C. A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy. Radiother Oncol. 2013 Apr;107(1):20-5.

28. Muren LP, Rossi C, Hug E, Lee A, Glimelius B. Establishing and expanding the indications for proton and particle therapy. Acta Oncol. 2013 Apr;52(3):459-62.

27. Worm ES, Høyer M, Fledelius W, Poulsen PR. Three-dimensional, Time-Resolved, Intrafraction Motion Monitoring Throughout Stereotactic Liver Radiation Therapy on a Conventional Linear Accelerator. Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):190-7.

26. Myhre S, Lingjærde OC, Hennessy BT, Aure MR, Carey MS, Alsner J, Tramm T, Overgaard J, Mills GB, Børresen-Dale AL, Sørlie T. Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins. Mol Oncol. 2013 Jun;7(3):704-18.

25. Maraldo MV, Aznar MC, Vogelius IR, Petersen PM, Specht L. Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1057-65.

24. Dieperink KB, Wagner L, Hansen S, Hansen O. Embracing life after prostate cancer. A male perspective on treatment and rehabilitation. Eur J Cancer Care (Engl). 2013 Jul;22(4):549-58.

22. Thörnqvist S, Muren LP, Bentzen L, Hysing LB, Høyer M, Grau C, Petersen JB. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets. Acta Oncol. 2013 Apr;52(3):521-7.

20. Andersen ES, Noe KO, Sørensen TS, Nielsen SK, Fokdal L, Paludan M, Lindegaard JC, Tanderup K. Simple DVH parameter addition as compared to deformable registration for bladder dose accumulation in cervix cancer brachytherapy. Radiother Oncol. 2013 Apr;107(1):52-7.

19. Sapru S, Mohamed S, Fokdal L, Nkiwane K, Swamidas J, Mahantshetty U, Kirisits C, Pötter R, Christian Lindegaard J, Tanderup K. Dose to the non-involved uterine corpus with MRI guided brachytherapy in locally advanced cervical cancer. Radiother Oncol. 2013 Apr;107(1):93-8.

18. Tanderup K, Nesvacil N, Pötter R, Kirisits C. Uncertainties in image guided adaptive cervix cancer brachytherapy: Impact on planning and prescription. Radiother Oncol. 2013 Apr;107(1):1-5.

17. Nygaard DE, Persson GF, Brink C, Specht L, Korreman SS. Evaluation of methods for selecting the midventilation bin in 4DCT scans of lung cancer patients. Acta Oncol. 2013 Nov;52(8):1715-22.

16. Mohamed S, Nielsen SK, Fokdal LU, Pedersen EM, Lindegaard JC, Tanderup K Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer Radiother Oncol. 2013 Apr;107(1):32-8.

15. Bøje CR, Dalton SO, Grønborg TK, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Overgaard J. The impact of comorbidity on outcome in 12 623 Danish Head and Neck Cancer Patients: A population based study from the DAHANCA database Acta Oncol. 2013 Feb;52(2):285-93.

14. Pagh A, Vedtofte T, Lynggaard CD, Rubek N, Lonka M, Johansen J, Andersen E, Kristensen CA, von Buchwald C, Andersen M, Godballe C, Overgaard J, Grau C. The value of routine follow-up after treatment for head and neck cancer. A National Survey from DAHANCA Acta Oncol. 2013 Feb;52(2):277-84.

12. Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA, Jespersen JB, Kristensen CA, Andersen E, Godballe C, Buchwald C, Bundgaard T, Johansen J, Lambertsen K, Primdahl H, Toustrup K, Sørensen JA, Overgaard J, Grau C. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer. 2013 May;49(7):1627-33.

11. Bernchou U, Agergaard SN, Brink C. Radiopaque marker motion during pre-treatment CBCT as a predictor of intra-fractional prostate movement. Acta Oncol. 2013 Aug;52(6):1168-74.

10. Lyngholm CD, Christiansen PM, Damsgaard TE, Overgaard J. Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncologica Feb 2013, Vol. 52, No. 2: 259–269.

7. Mortensen HR, Jensen K, Grau C. Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer. Acta Oncologica Feb 2013, Vol. 52, No. 2: 270–276.

6. Lønbro S, Dalgas U, Primdahl H, Overgaard J, Overgaard K. Feasibility and efficacy of progressive resistance training and dietary supplements in radiotherapy treated head and neck cancer patients - the DAHANCA 25A study. Acta Oncologica Feb 2013, Vol. 52, No. 2: 310–318.

5. Appelt AL, Vogelius IR, Bentzen SM. Modern Hypofractionation Schedules for Tangential Whole Breast Irradiation Decrease the Fraction Size-corrected Dose to the Heart. Clin Oncol (R Coll Radiol). 2013 Mar;25(3):147-52.

4. Busk M, Mortensen LS, Nordsmark M, Overgaard J, Jakobsen S, Hansen KV, Theil J, Kallehauge JF, D'Andrea FP, Steiniche T, Horsman MR. PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice. Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):186-97

3. Nawroth I, Alsner J, Deleuran BW, Dagnaes-Hansen F, Yang C, Horsman MR, Overgaard J, Howard KA, Kjems J, Gao S. Peritoneal macrophages mediated delivery of chitosan/siRNA nanoparticle to the lesion site in a murine radiation-induced fibrosis model. Acta Oncol. 2013 Nov;52(8):1730-8.

2. Appelt AL, Pløen J, Vogelius IR, Bentzen SM, Jakobsen A. Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):74-80.